Issue 25 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

25

June 24, 2005Jun 24, 2005

Free

DOWNLOAD THE PDF

Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say.

FDA orders “limited distribution” for lung cancer drug Iressa.

House approves $210 million for Dept. of Defense cancer research programs.

House Committee on Appropriations approves $28.5 billion for NIH.

House panel investigating NIH handling of tissue specimens.

Recent Issues

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026

Volume 52 | Issue 20 - May 22, 2026

Volume 52 | Issue 19 - May 15, 2026

Volume 52 | Issue 18 - May 08, 2026